In quantitative business, accuracy is an imperative, not an option. Quality strategy is at the heart of what we’ve done for more than 6 years.
Our team consists of specialists who are –
- Familiar with cross-over design and parallel design
- Familiar with ANOVA and ANCOVA analysis with mixed models
- Familiar with PK trials such as First-in-human (FIH) trials, drug-drug interaction (DDI) trials, Bio-equivalency (BE) trials, Bio-comparability (BC) trials, Bio-Availability (BA) trials, food effect trial, and PK for special populations trials (elderly, pediatrics, etc.).